Valeris Surpasses 2025 Goals Post-Merger, Eyes AI-Driven Expansion
Event summary
- Valeris (formed via March 2025 merger of Mercalis and PharmaCord) surpassed 2025 financial goals, adding 20+ new partners in Patient Support Services.
- Key hires include Jodi Dickinson (CPO), Peter Formisano (COO), and Manish Goel (CTO) to strengthen leadership.
- Market Access & Advisory Services segment grew >20% YoY, with Triangle Insights Group expanding client base by 50+ engagements.
- Valeris maintained ISO/IEC 27001 certification for data security management since 2018.
The big picture
Valeris's strong 2025 performance underscores the growing demand for integrated market access and patient support solutions in an increasingly complex US healthcare system. The company's focus on AI-driven innovation and scalable technology platforms positions it to capitalize on biopharma companies' need for end-to-end commercialization partners. With backing from private equity firms Permira and Odyssey Investment Partners, Valeris is well-capitalized to execute its expansion strategy.
What we're watching
- AI Integration
- How Valeris applies AI to patient engagement and market access will determine its competitive edge.
- Scalability Challenges
- Whether the company can sustain growth beyond integration while expanding capabilities across 500+ biopharma brands.
- Regulatory Compliance
- The pace at which Valeris adapts to evolving healthcare regulations will impact its long-term positioning.
Related topics